Salute e Benessere
Blood Gas Analyzer Market worth US$3.38 billion by 2030 with 4.6% CAGR | MarketsandMarkets™
the blood gas analyzer market is segmented based on sample type into arterial, venous, and capillary blood. In 2024, the arterial blood segment held the largest share of the market, as it provides the most accurate and reliable measurement of oxygen, carbon dioxide, and pH levels, which are critical for patient assessment. Arterial sampling is widely preferred in hospitals and critical care settings for routine monitoring and clinical decision-making, driving higher demand.
the blood gas analyzer market is segmented by application into critical care management, respiratory care, emergency care management, and other applications. In 2024, critical care management held the largest share, as patients in intensive care units require frequent monitoring of blood gas levels to manage critical and unstable health conditions. The high frequency of testing in ICUs, where multiple measurements may be performed per patient daily, drives substantial demand for blood gas analyzers in this application area.
, the blood gas analyzer market is divided into five key regions: North America , Europe , Asia Pacific , Latin America , and the Middle East & Africa . In 2024, North America held the largest share, primarily driven by its well-established diagnostics ecosystem, with the US as the primary contributor. This regional dominance is supported by strong healthcare infrastructure, a high prevalence of chronic and acute diseases, and significant investments in advanced diagnostic technologies and innovations.
The major players operating in this market are Danaher Corporation (US), Werfen S.A. ( Spain ), F. Hoffmann-La Roche Ltd. ( Switzerland ), Abbott Laboratories (US), Siemens Healthineers AG ( Germany ), Nova Biomedical (US), Medica Corporation (US), Techno Medica Co., Ltd. ( Japan ), IDEXX Laboratories, Inc. (US), EDAN Instruments, Inc. ( China ), and Guangzhou Wondfo Biotech Co., Ltd. ( China ).
is a leading player in the blood gas analyzer market due to its extensive global network and well-integrated operations, which allow the company to address diverse disease testing needs across multiple regions. Its robust distribution and service infrastructure ensure reliable product availability even in dynamic market conditions. Furthermore, the company strengthens its market leadership through strategic collaborations and partnerships that enhance its technological capabilities and expand its presence in high-growth segments of the diagnostics industry.
Werfen is one of the leading players in the blood gas analyzer market, driven by its innovative product portfolio and focus on advanced point-of-care solutions. Its strong global presence and efficient distribution network ensure timely access to its analyzers across diverse healthcare settings. Its continuous investment in research and development enables the introduction of new technologies and features that improve testing speed, reliability, and overall patient care.
For more information,
Get access to the latest updates on and
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, , and . With a , we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our , which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/blood-gas-analyzer-market-worth-us3-38-billion-by-2030-with-4-6-cagr--marketsandmarkets-302581819.html